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PElevated Pulmonary Artery Pressure
by Doppler Echocardiography Predicts
Hospitalization for Heart Failure and Mortality
in Ambulatory Stable Coronary Artery Disease
The Heart and Soul Study
Bryan Ristow, MD,* Sadia Ali, MD, MPH,† Xiushui Ren, MD,* Mary A. Whooley, MD,†
Nelson B. Schiller, MD, FACC*
San Francisco, California
Objectives We compared the predictive ability of tricuspid regurgitation (TR) and end-diastolic pulmonary regurgitation
(EDPR) gradients in outpatients with coronary artery disease.
Background The TR and EDPR gradients, in conjunction with right atrial pressure, provide Doppler estimates of pulmonary
artery systolic and diastolic pressures. We hypothesized that increases in TR or EDPR gradients in stable coro-
nary artery disease would predict heart failure (HF) hospitalization or cardiovascular (CV) death.
Methods We measured TR and EDPR gradients in 717 adults with completed outcome adjudications who were recruited
for the Heart and Soul Study. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for HF hospi-
talization, CV death, all-cause death, and the combined end point. Multivariate adjustments were made for age,
gender, race, history of CV or pulmonary disease, functional class, and left ventricular ejection fraction.
Results There were 63 HF hospitalizations, 19 CV deaths, and 86 all-cause deaths at the 3-year follow-up. There were
466 measurable EDPR gradients and 573 measurable TR gradients. Age-adjusted ORs for EDPR 5 mm Hg
predicted HF hospitalization (2.7, 95% CI 1.3 to 5.5, p  0.006), all-cause death (2.5, 95% CI 1.4 to 4.4, p 
0.002), and HF hospitalization or CV death (2.7, 95% CI 1.4 to 5.2, p  0.004). Age-adjusted OR for TR 30
mm Hg predicted HF hospitalization (3.4, 95% CI 1.9 to 6.2, p  0.0001) and HF hospitalization or CV death
(3.0, 95% CI 1.7 to 5.3, p  0.0001). Multivariate adjusted OR per 5-mm Hg incremental increases in EDPR pre-
dicted HF hospitalization or CV death (1.9, 95% CI 1.01 to 3.6, p  0.046) and all-cause death (1.7, 95% CI
1.05 to 2.8, p  0.03). Multivariate adjusted OR per 10-mm Hg incremental increases in TR predicted HF hospi-
talization or CV death (1.6, 95% CI 1.1 to 2.4, p  0.008).
Conclusions Increases in EDPR or TR gradients predict HF hospitalization or CV death among ambulatory adults with coro-
nary artery disease. (J Am Coll Cardiol 2007;49:43–9) © 2007 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.108(
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daised pulmonary artery (PA) pressure estimated by Dopp-
er echocardiography has been shown to predict mortality in
atients with acute myocardial infarction (1), aortic stenosis
rom the *Department of Medicine, Division of Cardiology, University of California,
an Francisco, California; and the †Department of Medicine, Veterans Affairs
edical Center, San Francisco, California. This study was supported by the
epartment of Veterans Affairs (Epidemiology Merit Review Program), the Robert
ood Johnson Foundation (Generalist Physician Faculty Scholars Program), the
merican Federation for Aging Research (Paul Beeson Faculty Scholars in Aging
esearch Program), the Nancy Kirwan Heart Research Fund, and a loan of
quipment from Siemens Corporation (Mountain View, California).a
Manuscript received February 27, 2006; revised manuscript received April 13,
006, accepted April 17, 2006.2), acute pulmonary embolism (3), and primary pulmonary
ypertension (4). Increased PA pressures also have been
hown to predict mortality in patients with end-stage liver
isease (5), human immunodeficiency virus infection (6),
cleroderma (7), and sickle cell disease (8).
The tricuspid regurgitation (TR) gradient, added to
chocardiographically estimated right atrial (RA) pressure,
as been found to correlate well with catheterization-
erived PA systolic pressure (9). End-diastolic pulmonary
egurgitation (EDPR) gradients added to RA pressure have
een found to correlate well with catheter-derived PA
iastolic pressures (10,11). We have previously shown that
n EDPR gradient 5 mm Hg is a independent marker of
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prognostic significance of an in-
creased EDPR gradient among
individuals with coronary artery
disease has not been evaluated.
We hypothesized that Doppler-
derived elevations in TR gradients
and EDPR gradients predict heart
failure (HF) hospitalization, car-
diovascular (CV) death, and all-
cause mortality in ambulatory
adults with coronary artery disease.
Methods
he Heart and Soul Study is a prospective cohort study
nvestigating the influence of psychosocial factors on CV
vents. The enrollment process for the Heart and Soul Study
as been previously described (13). Criteria for enrollment
ere: 1) history of myocardial infarction, 2) angiographic
vidence of at least 50% stenosis by area in at least 1 coronary
essel, 3) evidence of exercise-induced ischemia by treadmill
lectrocardiogram or stress nuclear perfusion imaging, 4) his-
ory of coronary revascularization, or 5) clinical diagnosis of
oronary artery disease as documented by an internist or
ardiologist. Individuals were excluded if they deemed them-
elves unable to walk 1 block or if they were planning to move
ut of the local area within 3 years. All study participants
rovided informed consent for baseline echocardiographic
esting, laboratory testing, and review of medical records. The
nstitutional review board at each of the enrolling centers
pproved the study protocol.
Figure 1 Tricuspid Regurgitation Gradient
On color flow Doppler signal, the highest tricuspid regurgitation gradient from para
Abbreviations
and Acronyms
CI  confidence interval
CV  cardiovascular
EDPR  end-diastolic
pulmonary regurgitation
HF  heart failure
OR  odds ratio
PA  pulmonary artery
RA  right atrium
TR  tricuspid
regurgitationricuspid and pulmonic regurgitation measurements.
chocardiographic studies were performed in the standard left
ateral recumbent and supine positions with a commercially
vailable ultrasound system with harmonic imaging (Acuson
equoia, Siemens Corp., Mountain View, California). The TR
et was visualized with color flow mapping, and the TR
radient was measured with continuous wave Doppler (Fig. 1).
e used the modified Bernoulli equation (delta P  4 v2) to
alculate gradients from velocities. Because our initial in-
estigations of the EDPR gradient generated more intense
nterest in echocardiographic estimates of PA pressures
12), we changed our analysis protocol to include multiple
iews for detection of TR instead of the parasternal long axis
lone. The peak TR gradient for the current study was the
ighest measurement obtainable by Doppler imaging among
arasternal, apical, and subcostal views. We did not seek to add
n estimate of RA pressure into the analyses because we
ypothesized that measured gradients alone would have statis-
ically significant power in predicting adverse outcomes. A
ingle technician made all sonographic measurements, and a
ingle cardiologist reader (N.B.S.), who was blinded to clinical
nd laboratory information, evaluated each echocardiogram.
The PR wave form was sought from the standard basal
arasternal short-axis view by color flow interrogation across
he pulmonic valve. The velocity was measured at end-
iastole at termination of reverse flow after the “a”-wave
Fig. 2). This point of measurement also corresponded with
he first peak deflection of the QRS complex (usually the
-wave). To minimize the significance of respiratory vari-
tion, the sonographer screened at least 10 cardiac cycles
ith the patient breathing quietly at rest and chose the
l, apical, or subcostal views is recorded. The apical view is shown.sterna
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January 2/9, 2007:43–9 Pulmonary Artery Pressure by Echocardiographyighest value for measurement. Formal evaluation of the
DPR gradient occurred in the 741 participants enrolled
etween July 2001 and December 2002.
Although studies suggest that TR gradients normally
ncrease with age (14), we sought to investigate the predic-
ive power of 5- and 10-mm Hg increases in EDPR and
R, respectively. We also sought to determine the prognos-
ic significance of a single cutoff point in predicting out-
ome. Studies in young healthy individuals with normal
ardiac output suggest that the upper limit of normal for the
R gradient, when evaluated independently of RA pressure,
hould be 30 mm Hg (15,16). We previously have validated
mm Hg as the upper limit of normal for the EDPR
radient (12).
ardiovascular outcomes. We conducted telephone
ollow-up interviews and questioned participants or their
roxies regarding recent emergency room visits, hospitaliza-
ions, or death. Medical records, death certificates, and
oroner’s reports were retrieved. Two blinded adjudicators
eviewed each event and, if there was agreement, the
utcome classification was binding. If there was disagree-
ent, a third blinded adjudicator reviewed the event and
etermined the outcome classification.
Hospitalization for HF was defined for a clinical syn-
rome with a minimum 1-night hospital stay and involving
t least 2 of the following: paroxysmal nocturnal dyspnea,
rthopnea, elevated jugular venous pressure, pulmonary
ales, a third heart sound, cardiomegaly on chest radiogra-
hy, or pulmonary edema on chest radiography. These
linical signs and symptoms must have represented a clear
Figure 2 End-Diastolic Pulmonary Regurgitation Gradient
On color Doppler signal from the parasternal short axis, the end-diastolic pulmona
at the first peak deflection of the QRS on electrocardiogram, corresponding with tehange from the normal clinical state of the patient and oust have been accompanied by either failing cardiac output
s determined by peripheral hypoperfusion (in the absence
f other causes such as sepsis or dehydration) or peripheral
r pulmonary edema treated with intravenous diuretics,
notropes, or vasodilators.
Mortality adjudications were based on hospital records,
eath certificates, and autopsy results. Death was consid-
red due to CV causes if the death certificate listed acute
yocardial infarction, congestive HF, or arrhythmia as
he primary cause of death. Sudden death also was
onsidered CV if it was unexpected, otherwise unex-
lained, and occurred within 1 h of the onset of terminal
ymptoms.
tatistical analysis. We included only those participants
ith completed outcome adjudications (717 patients) in
he analyses. Baseline characteristics are reported as the
ean plus or minus standard deviation for continuous
ariables and as percentages for categorical variables.
ifferences in baseline characteristics between groups of
tudy participants were determined using the Student t
est for continuous variables and the chi-square test for
ichotomous variables. We used logistic regression to
alculate odds ratios (ORs) for predictor variables and
utcome. We report ORs with 95% confidence intervals.
-statistics were recorded for PR and TR as predictors of
F hospitalization and CV death. Analyses were calcu-
ated using software (Statistical Analysis, Version 8, SAS
nstitute Inc., Cary, North Carolina). Predefined end
oints were HF hospitalization, CV death, all-cause
eath, and the combined end point of HF hospitalization
rgitation gradient is measured
tion of reverse flow across the pulmonic valve.ry regu
rminar CV death.
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f the 717 participants with completed outcome adjudica-
ions who were enrolled between July 2001 and December
002, 466 (65%) had measurable EDPR gradients, 573
80%) had measurable TR gradients, and 392 (55%) had
oth measurable EDPR and TR gradients. Among those
ndividuals without measurable TR gradients, 74 (10% of
he total) had measurable EDPR gradients. Considering
ither EDPR or TR as a measuring tool increased the yield
f estimates of PA pressure to 90% of the study population.
Of those with measurable EDPR, there were 96 individ-
als (21%) with an EDPR gradient 5 mm Hg. Of those
ith measurable TR, there were 126 individuals (22%) with
TR gradient 30 mm Hg. The proportion of individuals
ith an increased EDPR gradient was similar whether TR
as measurable (20%) or not (23%). The proportion of
ndividuals with an elevated TR gradient also was similar
hether EDPR was measurable (23%) or not (19%).
aseline Characteristics of Study Participants
Table 1 Baseline Characteristics of Study Participants
EDPR <5 mm Hg
(n  370)
EDPR >5 mm
(n  96)
Age (yrs) 65 12 66 11
Male gender 283 (76%) 73 (76%)
Body mass index (kg/m2) 28 5 28 5
Body surface area (m2) 1.9 .22 1.9 .20
Race
White 217 (59%) 50 (52%)
Black 59 (16%) 23 (24%)
Asian 57 (15%) 12 (13%)
Other 36 (10%) 11 (11%)
Medical history
Hypertension 244 (66%) 72 (75%)
MI 186 (50%) 52 (55%)
Stroke 51 (14%) 15 (16%)
COPD 58 (16%) 18 (19%)
Diabetes 71 (19%) 32 (33%)
Revascularization 219 (59%) 54 (57%)
HF 45 (12%) 26 (27%)
NYHA functional class II, III, or IV 210 (57%) 70 (73%)
Minimal or no physical activity 127 (34%) 44 (46%)
Current smoker 69 (19%) 17 (18%)
Alcohol use 108 (30%) 23 (24%)
LVEF 0.63 .09 0.57 .11
alues are n (%) unless otherwise specified.
COPD chronic obstructive pulmonary disease; EDPR end-diastolic pulmonary regurgitation; H
eart Association; TR  tricuspid regurgitation.
utcomes at 3 Years
Table 2 Outcomes at 3 Years
EDPR <5 mm Hg
(n  370)
EDPR >5 mm H
(n  96)
HF hospitalization 23 (6%) 15 (16%)
CV death 10 (3%) 5 (5%)
All-cause death 41 (11%) 23 (24%)
HF hospitalization or CV death 27 (7%) 17 (18%)alues are n (%).
CV  cardiovascular; other abbreviations as in Table 1.Baseline characteristics of study participants are shown
n Table 1. Statistically significant differences were
resent between normal and elevated gradients with
egard to age, physical activity, New York Heart Associ-
tion functional class, and left ventricular ejection frac-
ion. Statistically significant differences also were present
ith regard to diabetes mellitus, prior stroke, and history
f HF.
During a mean follow up of 3 years, there were 63
ospitalizations for HF, 19 CV deaths, and 86 all-cause
eaths. The number of participants with outcome events
eparated by PR and TR gradients is listed in Table 2.
he age-adjusted ORs for EDPR 5 mm Hg and
R 30 mm Hg for predicting outcome are shown in
able 3.
Multivariate adjusted analyses for age, gender, body mass
ndex, body surface area, body mass index, ethnicity, history
f hypertension, myocardial infarction, stroke, chronic ob-
p Value
TR <30 mm Hg
(n  447)
TR >30 mm Hg
(n  126) p Value
0.33 65 11 69 12 0.0008
0.93 332 (74%) 94 (75%) 0.94
0.82 28 5 28 6 0.30
0.81 1.9 .22 1.9 .22 0.95
0.24 258 (58%) 69 (55%) 0.55
0.07 83 (19%) 28 (22%) 0.36
0.47 57 (13%) 15 (12%) 0.80
0.62 49 (11%) 14 (11%) 0.96
0.10 305 (68%) 94 (75%) 0.13
0.45 234 (53%) 66 (53%) 0.98
0.64 54 (12%) 29 (23%) 0.002
0.47 68 (15%) 27 (21%) 0.10
0.003 98 (22%) 32 (25%) 0.42
0.68 259 (58%) 83 (66%) 0.09
0.0003 76 (17%) 25 (20%) 0.47
0.004 263 (59%) 88 (70%) 0.03
0.04 149 (33%) 57 (45%) 0.01
0.83 91 (20%) 25 (20%) 0.89
0.30 135 (30%) 36 (29%) 0.82
0.0001 .62 .09 .60 11 0.04
art failure; LVEF left ventricular ejection fraction; MImyocardial infarction; NYHA New York
p Value
TR <30 mm Hg
(n  447)
TR >30 mm Hg
(n  126) p Value
0.003 28 (6%) 26 (21%) 0.0001
0.21 11 (2%) 5 (4%) 0.36
0.001 49 (11%) 22 (17%) 0.05
0.002 33 (7%) 27 (21%) 0.0001Hgg
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January 2/9, 2007:43–9 Pulmonary Artery Pressure by Echocardiographytructive pulmonary disease, diabetes mellitus, prior coro-
ary revascularization, prior HF, smoking, alcohol con-
umption, physical activity, New York Heart Association
unctional class, and left ventricular ejection fraction are
isted in Table 4. Each 5-mm Hg increase in EDPR was
ssociated with a 2.5-fold increased OR for HF hospital-
zation. Each 10-mm Hg increase in TR was associated
ith a 50% increased OR for HF hospitalization. Each
-mm Hg increase in EDPR also was associated with a 70%
ncreased OR for all-cause death.
For the 55 individuals who had only increased rates of TR
30 mm Hg with normal EDPR), 11% had HF hospital-
zation or CV death. For the 43 individuals with only
levated EDPR (5 mm Hg with normal TR), 9% had HF
ospitalization or CV death. For the 36 individuals with
oth elevated TR and EDPR, 36% had HF hospitalization
r CV death. The number of individuals with HF hospi-
alization or CV death for groups of participants divided by
DPR or TR gradients is shown in Figure 3. C-statistics
ere similar for EDPR and TR in predicting HF hospital-
zation (EDPR 0.71, TR 0.66) and CV death (EDPR 0.57,
R 0.60), indicating that the tests have similar predictive
ower. C-statistics for predicting all-cause mortality showed
lightly better predictive power for EDPR (0.66) than for
R (0.57).
iscussion
oppler measurements of TR and EDPR gradients predict
F hospitalization and mortality among ambulatory adults
ith coronary artery disease. Previous studies have shown
hat Doppler estimated elevations in PA systolic pressure
redict mortality in a variety of disease states, and the
urrent study extends the adverse prognostic significance of
levated TR to adults with stable coronary artery disease.
Age-Adjusted Odds Ratios (With 95% ConfidencInt rvals) for Elevated EDPR and TR gradients
Table 3 Age-Adjusted Odds Ratios (With 95Intervals) for Elevated EDPR and TR
EDPR
>5 mm Hg
HF hospitalization 2.7 (1.3–5.5)
CV death 1.9 (0.64–5.8)
All-cause death 2.5 (1.4–4.4)
HF hospitalization or CV death 2.7 (1.4–5.2)
Abbreviations as in Tables 1 and 2.
Multivariate-Adjusted* Odds Ratios (With 95% CIntervals) per 5-mm Hg Increase in EDPR or 10-
Table 4 Multivariate-Adjusted* Odds RatiosIntervals) per 5-mm Hg Increase in
EDPR 5-mm Hg
Increase
HF hospitalization 2.5 (1.2–4.9)
CV death 1.2 (0.45–3.0)
All-cause death 1.7 (1.05–2.8)
HF hospitalization or CV death 1.9 (1.01–3.6)*Multivariate adjustments are made for all variables in Table 1.
Abbreviations as in Tables 1 and 2.he current study also illustrates the prognostic impact of
he EDPR gradient.
The EDPR gradient is a clinically useful measurement
or multiple reasons. The measurement is simple to make
rom the parasternal short axis, and it involves a single
aliper placement along a Doppler signal. In such cases
here the TR signal does not provide a measurable
aveform, the EDPR gradient can provide a measurable
stimate of PA diastolic pressure. Although our initial
nvestigations into Doppler estimates of PA pressures
eported measurable TR gradients from the parasternal
iew in 61% of patients (12), we achieved a greater
ercentage of measurable TR gradients by incorporating
he apical and subcostal views for measuring TR. The
ddition of EDPR measurements to TR measurements
ncreased the yield of information about PA pressure
rom 80% to 90% in our study population.
The EDPR gradient correlates with catheter-derived PA
iastolic pressure and may be a wedge pressure analog and a
easure of LV end diastolic pressure. An increased EDPR
radient was significantly associated with history of HF at
aseline (Table 1), whereas the TR gradient was not. Both
DPR and TR predict future HF hospitalizations, but a
ossible difference in prognostic information from each
radient merits further study.
Although TR is measured from the apical, parasternal, or
ubcostal views, the EDPR gradient is measured in the
arasternal axis. Important technical considerations in mea-
uring the EDPR gradient are: 1) inclusion of the highest
DPR gradient among several cycles of quiet respiration,
nd 2) measurement along the first-peak deflection of the
RS complex. In those cases in which the pulmonary
egurgitation waveform ended before the onset of the QRS
omplex, we did not include a measurable EDPR gradient
nfidence
dients
p Value
TR
>30 mm Hg p Value
0.006 3.4 (1.9–6.2) 0.0001
0.25 1.5 (0.51–4.5) 0.46
0.002 1.5 (0.87–2.7) 0.14
0.004 3 (1.7–5.3) 0.0001
enceg Increase in TR
h 95% Confidence
or 10-mm Hg Increase in TR
p Value
TR 10-mm Hg
Increase p Value
0.01 1.5 (1.03–2.2) 0.03
0.75 1.3 (0.83–2.2) 0.23
0.03 1.2 (0.85–1.6) 0.33
0.05 1.6 (1.1–2.4) 0.008e
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Pulmonary Artery Pressure by Echocardiography January 2/9, 2007:43–9n the analyses. We have shown previously that the corre-
ation coefficient for interobserver variability for EDPR
easurements was 0.98, indicating that the measurement is
eproducible (12).
tudy limitations. Several limitations of our study must be
onsidered. First, the study population was predominantly
ale, and the results may not apply to women. Second, for
implification, we did not add RA pressure to our measure-
ents of EDPR or TR. As is typical of an ambulatory
opulation, most (92%) of the individuals in the current
tudy had a normal RA pressure of 5 mm Hg or less. Third,
e did not correct pressure gradients for cardiac output,
hich could provide an analog for pulmonary vascular
esistance (17). Other methods of estimating PA pressure
y echocardiography also were not evaluated in the present
tudy (10,18,19).
Although multivariate-adjusted incremental increases in
DPR and TR were significant for predicting HF hospi-
alization and the combined end point of HF hospitaliza-
ion or CV death, the OR of EDPR or TR gradients for
redicting CV death were not statistically significant. The
mall number of adjudicated CV deaths in the study (19
atients) could explain the lack of statistical significance.
onclusions. Doppler measured EDPR and TR gradients
redict HF hospitalization and the combined end point of
F hospitalization and CV mortality among ambulatory
dults with stable coronary artery disease. The EDPR
radient also predicted all-cause mortality. We propose that
DPR and TR should be measured routinely in transtho-
acic echocardiograms to estimate PA pressure. Each level
f progressive elevation in PA pressure has adverse prog-
ostic significance, whereas the greatest levels of EDPR and
R increases in stable coronary artery disease are markedly
redictive of HF hospitalization or CV death. The use of
DPR and TR may have applicability to patients with
Figure 3 Percent Hospitalization for HF or CV Death by Elevatio
Percent of patients with the combined outcome (heart failure [HF] hospitalization o
by elevations in end-diastolic pulmonary regurgitation (EDPR) or tricuspid regurgitaiseases of other organ systems, and future studies will beelpful to determine the predictive value of elevated TR or
DPR gradients among other populations.
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